{"id":3915,"date":"2026-08-01T13:38:29","date_gmt":"2026-08-01T13:38:29","guid":{"rendered":"https:\/\/medtis.ch\/?p=3915"},"modified":"2026-08-11T13:39:57","modified_gmt":"2026-08-11T13:39:57","slug":"ak26","status":"publish","type":"post","link":"https:\/\/medtis.ch\/en\/2026\/08\/01\/ak26\/","title":{"rendered":"Advances\u00a0in\u00a0Keratinocytic\u00a0Precancer Management\u00a0"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Save the Date:<\/strong><\/h1>\n\n\n\n

29 January 2027 | 09:00 – 17:15<\/p>\n\n\n\n

Language: English<\/p>\n\n\n\n

Format: In-person event<\/p>\n\n\n\n

<\/div>\n\n\n\n

We are delighted to invite you to the first Advances in Keratinocytic Precancer Management Congress<\/strong>, a new scientific meeting dedicated exclusively to the latest developments in the diagnosis, prevention, and treatment of keratinocytic precancers.<\/p>\n\n\n\n

Join leading international experts for a day of cutting-edge science, practical insights, interactive discussions, and future perspectives. From disease biology and risk assessment to evidence-based therapies, current guidelines and novel therapeutic approaches, the programme will provide valuable insights for clinical practice and research.<\/p>\n\n\n\n

Beyond the scientific programme, the congress offers excellent opportunities to connect with colleagues, researchers, and experts from across the field.\u00a0<\/p>\n\n\n\n

We look forward to welcoming you for a day of learning, exchange, and collaboration.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Scientific Committee<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Programme<\/strong><\/p>\n\n\n\n

The congress programme will be available soon. Stay tuned for further updates.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Venue<\/strong><\/p>\n\n\n\n

kHaus, Kasernenstrasse 8, Basel, Switzerland
10-15 minutes from Basel SBB by tram<\/p>\n\n\n\n

<\/div>\n\n\n\n

Registration<\/strong><\/p>\n\n\n\n

Registration exclusively for healthcare professionals.
Participation fee:<\/strong> CHF 150 per person.
Registration will open shortly. We look forward to welcoming you to the congress.<\/p>\n\n\n\n

<\/div>\n\n\n\n

CME credits<\/strong><\/p>\n\n\n\n

CME accreditation has been requested from the Swiss Society of Dermatology and Venereology (SSDV).<\/p>\n\n\n\n

<\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

1st Advances in Keratinocytic Precancer
\nManagement Congress<\/p>","protected":false},"author":6,"featured_media":3582,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[51,157,45],"tags":[208],"class_list":["post-3915","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dermatology","category-gp","category-oncology","tag-29-january-2027"],"_links":{"self":[{"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/posts\/3915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/comments?post=3915"}],"version-history":[{"count":7,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/posts\/3915\/revisions"}],"predecessor-version":[{"id":3978,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/posts\/3915\/revisions\/3978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/media\/3582"}],"wp:attachment":[{"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/media?parent=3915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/categories?post=3915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medtis.ch\/en\/wp-json\/wp\/v2\/tags?post=3915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}